Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David P. Douglass
Observed name:
David Douglass
Institution:
University of Arkansas for Medical Sciences
Observed institutions:
Arkansas Children's Hospital,
University of Arkansas Medical Center,
Arkansas Children's Research Institute,
University of Arkansas for Medical Sciences
ORCID:
0000-0001-5245-0917
Observed ORCID:
0000-0001-5245-0917
OpenAlex ID:
A5015213926
Primary superficial Ewing sarcoma: A unique entity? A case report including novel findings of ELF3 and TNFRSF14 copy number loss
2020
·
Linda D. Murphy
, Gray M. Orman
, et al.
·
Journal of Cutaneous Pathology
·
10
Development and validation of a 21-gene prognostic signature in neuroblastoma
2023
·
Mehul Gupta
, Sunand Kannappan
, et al.
·
Scientific Reports
·
8
PDF
The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors
2022
·
David P. Douglass
, Fariba Navid
, et al.
·
Pediatric Drugs
·
6
Clinical features and outcomes of young patients with low‐grade non‐rhabdomyosarcoma soft tissue sarcomas treated with a risk‐based strategy: A report from Children's Oncology Group study ARST0332
2024
·
David P. Douglass
, Cheryl M. Coffin
, et al.
·
Pediatric Blood & Cancer
·
4
PDF
Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children’s Oncology Group
2025
·
Jacquelyn N. Crane
, David P. Douglass
, et al.
·
European Journal of Cancer
·
2
Cancer-associated fibroblasts promote tumor progression in fusion-positive rhabdomyosarcoma
2025
·
Patrick Sipila
, Son Tran
, et al.
·
Scientific Reports
·
1
PDF
Neonatal osteoblastic tumor with a novel PTBP1::FOSB fusion
2023
·
Patrick R. Blackburn
, David P. Douglass
, et al.
·
Genes Chromosomes and Cancer
·
1
Abstract 1558: Targeting CDK9 via the small-molecule inhibitor enitociclib as a therapeutic strategy to treat MYCN-amplified rhabdomyosarcoma and neuroblastoma in children
2023
·
Son Tran
, Patrick Sipila
, et al.
·
Cancer Research
·
1
A Novel Germline TP53 Mutation in a Patient With Li-Fraumeni Syndrome: Resolving a Variant of Uncertain Significance
2021
·
David P. Douglass
, Kimo C. Stine
, et al.
·
Journal of Pediatric Hematology/Oncology
·
1
PDF
Correction: Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study
2026
·
Taewon Lee
, David Douglass
, et al.
·
Cardiovascular Toxicology
PDF
Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study
2025
·
Taewon Lee
, David Douglass
, et al.
·
Cardiovascular Toxicology
Show more works
View as search
Works count:
11
Citation count:
34
H-index:
4
I10-index:
1
Year
Topic
Type